Home
Conditions
Lymphoma, B-Cell, Marginal Zone

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

645 public trials 88 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

NCT00003883

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

NCT00004157

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +94 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

NCT00014391

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

NCT00003082

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00006042

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations: New York Presbyterian Hospital - Cornell Campus New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

VELCADE in MALT Lymphoma Pretreated With Prior Systemic Therapy

NCT00210327

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland

View Trial Details

Completed

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

NCT00373646

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Department of Internal Medicine I Vienna, Austria

View Trial Details

Active, Not Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

NCT05753501

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations: Arizona Oncology - Tucson - Wilmot Road /ID# 252351 Tucson, Arizona, United States

UC Irvine Medical Center /ID# 263020 Orange, California, United States

Stanford University - Palo Alto /ID# 249683 Palo Alto, California, United States

Rocky Mountain Cancer Centers - Lone Tree /ID# 252237 Lone Tree, Colorado, United States

View all 51 locations

View Trial Details

Lymphoma, B-Cell, Marginal Zone

Lymphoma, B-Cell, Marginal Zone trial results

Related conditions